Literatur
Mendenhall WM, Million RR, Pfaff WW (1983) Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 9(7):977–985
Heald RJ et al (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 133(8):894–899
Kapiteijn E et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646
Sebag-Montefiore D et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373(9666):811–820
Heald RJ, Moran BJ (1998) Embryology and anatomy of the rectum. Semin Surg Oncol 15(2):66–71
Fujita S et al (2017) Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a Multicenter, randomized controlled, Noninferiority trial. Ann Surg 266(2):201–207
Ogura A et al (2019) Neoadjuvant (Chemo)radiotherapy with total Mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the Multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol 37(1):33–43
Pares O et al (2016) otal Mesorectal irradiation: the “next step” in the multidisciplinary management of rectal adenocarcinoma? Dis Colon Rectum 59(12):1222–1226
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Gani und D. Zips sind Mitarbeiter der Klinik für Radioonkologie, die finanzielle und technische Unterstützung von der Fa. Elekta AB (Stockholm, Schweden) im Rahmen einer Forschungskooperation sowie finanzielle Unterstützung für Fortbildungsveranstaltungen von der Fa. Dr. Sennewald GmbH, München, erhält. Das chirurgische Trainingszentrum Tübingen (Leiter: PD Dr. A. Krirschniak) erhält Unterstützung von der Fa. Karl Storz Endoskopie GmbH, Tuttlingen, Fa. Takeda, Fa. Medtronic, Fa. Ethicon und Fa. Erbe Elektromedizin, Tübingen. A. Kirschniak erhielt Rednerhonorare der Fa. Falk, Fa. Takeda und Fa. Jansen.
Additional information
Originalpublikation
Ogura A, Konishi T, Cunningham C et al (2019) Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol 37(1):33–43
Rights and permissions
About this article
Cite this article
Gani, C., Kirschniak, A. & Zips, D. Lateral pelvine Lymphknoten beim lokal fortgeschrittenen Rektumkarzinom – eine unterschätzte Rezidivlokalisation?. Strahlenther Onkol 195, 576–578 (2019). https://doi.org/10.1007/s00066-019-01447-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-019-01447-4